Making a Difference

Cervilenz Inc. is dedicated to making a difference in the world of prematurity. As a company, we take pride knowing that the CerviLenz device will help clinicians give pregnant women the best possible care while also helping to reduce the cost of care.

Cervilenz Inc. was founded in 2008 by Michael Ross, MD, MPH, Rosalyn Baxter-Jones, MD, and Dean Koch. The company headquarters is in the beautiful village of Chagrin Falls – a suburb of Cleveland, Ohio.

Dean Koch is President and CEO and a member of the Board of Directors. Dean has over 20 years of experience with novel medical devices, diagnostics, and therapeutics. At Adeza Biomedical, Dean led the commercialization of a laboratory test for preterm birth prediction and the market planning for a new drug for preterm birth prevention. As Vice President of Sales, Dean built the sales organization to over 100 sales representatives and managers. Dean also served as Vice President of Marketing from 2006 until the sale of Adeza to Cytyc, Inc. in 2007 for $450 million. Cytyc has since merged with Hologic, Inc.

Melanie Sweeney is Vice President, Marketing. Melanie brings 15 years of experience in the world of prematurity to Cervilenz Inc. from her work with the March of Dimes in marketing, fundraising, and volunteer engagement. With a degree in engineering design, Melanie worked as a Human Factors Analyst for Comsis Corporation. In addition, she launched and managed a community-based nonprofit organization, Partners in Intensive Care.

Michael Ross, MD, MPH is Medical Director and a member of the Board of Directors. Dr. Ross is board certified in Maternal-Fetal Medicine and a member of the faculty at Harbor-UCLA Medical Center in Los Angeles, CA. Dr. Ross has authored over 300 peer reviewed clinical publications.

Rosalyn Baxter-Jones, MD invented the CerviLenz device, inspired by her need for a new way to identify patients who may be at high risk of preterm birth. Dr. Baxter-Jones is a practicing Obstetrician/Gynecologist in San Diego, California.

Making it Happen

Cervilenz Inc. is grateful for the funding provided by these and other valued investors.

Stay in touch on Facebook

Get announcements and research updates, learn more about how obstetricians and midwives are using the CerviLenz device, and interact with us and your colleagues. Plus, get all the latest news on preterm birth risk assessment, cervical length measurement, high risk patient management, therapies such as progesterone, and more!

Connect with us on Facebook